Insider Selling: Schrödinger, Inc. (NASDAQ:SDGR) Insider Sells 16,723 Shares of Stock

Schrödinger, Inc. (NASDAQ:SDGR - Get Free Report) insider Karen Akinsanya sold 16,723 shares of Schrödinger stock in a transaction on Monday, April 14th. The shares were sold at an average price of $25.09, for a total value of $419,580.07. Following the sale, the insider now directly owns 15,625 shares of the company's stock, valued at approximately $392,031.25. The trade was a 51.70 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Schrödinger Trading Up 2.1 %

Schrödinger stock traded up $0.54 on Friday, reaching $25.75. 1,141,814 shares of the stock were exchanged, compared to its average volume of 825,065. Schrödinger, Inc. has a twelve month low of $16.60 and a twelve month high of $28.47. The firm has a fifty day moving average price of $22.01 and a two-hundred day moving average price of $21.00. The stock has a market cap of $1.88 billion, a PE ratio of -11.00 and a beta of 1.77.

Schrödinger (NASDAQ:SDGR - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The company reported ($0.55) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.20). The business had revenue of $88.32 million for the quarter, compared to analyst estimates of $83.20 million. Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. Equities analysts anticipate that Schrödinger, Inc. will post -2.37 EPS for the current fiscal year.

Institutional Investors Weigh In On Schrödinger

Several hedge funds and other institutional investors have recently modified their holdings of SDGR. Stanley Laman Group Ltd. grew its position in Schrödinger by 17.3% in the 1st quarter. Stanley Laman Group Ltd. now owns 186,980 shares of the company's stock worth $3,691,000 after purchasing an additional 27,511 shares during the last quarter. Greenwood Capital Associates LLC grew its position in Schrödinger by 2.7% during the first quarter. Greenwood Capital Associates LLC now owns 23,139 shares of the company's stock worth $457,000 after buying an additional 612 shares in the last quarter. GAMMA Investing LLC increased its stake in Schrödinger by 118.5% during the first quarter. GAMMA Investing LLC now owns 6,109 shares of the company's stock valued at $121,000 after acquiring an additional 3,313 shares during the period. Harbor Capital Advisors Inc. raised its holdings in Schrödinger by 32.4% in the 1st quarter. Harbor Capital Advisors Inc. now owns 15,005 shares of the company's stock valued at $296,000 after acquiring an additional 3,676 shares in the last quarter. Finally, United Advisor Group LLC raised its holdings in Schrödinger by 3.3% in the 4th quarter. United Advisor Group LLC now owns 19,769 shares of the company's stock valued at $381,000 after acquiring an additional 634 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on SDGR. KeyCorp raised their price objective on shares of Schrödinger from $30.00 to $32.00 and gave the company an "overweight" rating in a research report on Wednesday. Piper Sandler cut their price target on shares of Schrödinger from $50.00 to $45.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Buy" and an average price target of $33.00.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.